NYSE: NSRX Lily: Hello, and welcome to the Life Sciences Investor Forum. On behalf of OTC Markets and our co-host, Zacks Small Cap Research, we are very pleased you have joined us. The next ...

AM/FM radio and podcasts convert exposure into nasal/allergy relief brand loyalty better than TV, despite receiving a ...

A preliminary report issued by federal safety investigators didn't flag any serious safety failures that could have led to the fiery crash of a plane last month on a skydiving outing in Missouri ...

NASARIX achieves positive biological safety resultsShares of Polyrizon Ltd. (NASDAQ:PLRZ) gained 10% on Friday after the ...

Afrin, an over-the-counter nasal decongestant spray, has clear instructions on its packaging: Do not use for more than three days. That's because it works wonders to unclog your nose, but use for more ...

No new commercial formulary additions or coverage decisions issued for neffy (epinephrine nasal spray) in the July 1, 2026 cycle; company to continue payer discussions for potential future inclusion ...

ARS Pharmaceuticals, Inc. shares fell in after-hours trading on Wednesday after the company provided commercial and financial ...

Many patients will continue to face higher out-of-pocket costs or rely on the company’s cash-pay option without broader ...

No new commercial formulary additions or coverage decisions issued for neffy (epinephrine nasal spray) in the July 1, 2026 cycle; company to ...

Physician Growth Partners ("PGP"), a leading healthcare investment banking firm, is pleased to announce it advised Lakeshore Ear, Nose, Throat Center ("Lakeshore ENT") in the group's partnership with ...

ALK has received marketing authorisation from the UK's Medicines and Healthcare products Regulatory Agency (MHRA) for EURneffy 1mg, a needle-free adrenaline treatment for children ...

The study is enrolling up to 300 US patients with CRS to evaluate the ESSpand DCB with endoscopic sinus surgery.